Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

December 15, 2015 by Alan Khadavi

Eosinophilic Esophagitis in Southern California

Eosinophilic esophagitis in Southern California was studied using data from members of Kaiser Permanente Southern California.  This was was the first population based study to evaluate Eosinophilic esophagitis epidemiology representative of the community it serves.  This study was published in the Journal of Allergy and Clinical Immunology in Practice, November/December 2015.  Eosinophilic esophagitis has been reported to affect more men than woman, more adults than children, and more white individuals than those from minority backgrounds.  Eosinophilic esophagitis in Southern California was studied using 14 medical Kaiser centers located in Los Angeles, Orange, San Bernardino, San Diego, Kern, Riverside and Ventura counties.

Eosinophilic esophagitis was diagnosed in 1,500 of 3.5 million patients.  Approximately 1300 adults and 200 children.  Males were higher than females and the age did not matter.  Overall, whites had a significantly higher prevalence among blacks, Asians and Hispanics.

Eosinophilic esophagitis was 4 times more common from households with higher annual income than in those from the lowest.

Overall Eosinophilic esophagitis in Southern California was observed in adults (86%) compared to children (14%). Eosinophilic esophagitis was 2.1 times more frequently in men than in women.

We previously discussed Eosinophilic Esophagitis extensively in a previous blog https://allergylosangeles.com/allergy-blog/eosinophilic-esophagitis-eoe/

Another study published in the same journal looked at the management of refractory Eosinophilic esophagitis.  They found through a combination of diet therapy and/or topical steroids in Eosinophilic esophagitis can achieve remission of their disease.  Milk, egg and wheat were the 3 most common food triggers identified.  Histological remission was defined as less than 10 eosinophils/hpf.  Other foods identified in the study were beef, corn, soy, seafood, nuts, rice and beans.  Sometimes a second attempt in diet elimination was needed in patients to achieve remission.  Many patients who attempted it the first time were not able to follow the diet because of its severe restriction.  A more limited diet restriction with less foods can be more productive in some patients.    The topical corticosteroids used were fluticasone 110-220, 2 puffs twice a day or viscous budesonide, 1-6 mg/day in single or divided dosages.  This is similar to the treatment we discussed in a previous post https://allergylosangeles.com/allergy-blog/eosinophilic-esophagitis-treatment-options/

If all of this fails, there are future possible treatment options on the horizon https://allergylosangeles.com/allergy-blog/cinquil-reslizumab-for-eosinophil-disorders/

If you have been diagnosed with eosinophilic esophagitis, your gastroenterologist should work together with your allergist to find the best treatment options for you.

Filed Under: Blog, Food allergy, Los Angeles

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page